Tri Chemical Laboratories Inc.

Tri Chemical Laboratories Inc. faced a notable decline in stock value today, contrasting with the broader market's performance. Despite recent downturns, the company has shown resilience over the past year and maintains a strong financial position, characterized by low debt and healthy growth in net sales.

Tri Chemical Laboratories Inc. has seen notable stock performance, with significant gains over various time frames. The company maintains a strong financial position, characterized by high return on equity and low debt levels. Despite recent underperformance compared to the broader market, it demonstrates healthy long-term growth potential.

Tri Chemical Laboratories Inc. has recently experienced a change in its valuation score, indicating a more balanced perspective on its market position. The company showcases solid financial metrics, including a P/E ratio of 16 and a return on equity of 16.68%, alongside low debt levels and significant cash reserves.

Tri Chemical Laboratories Inc. has seen significant gains, reaching an intraday high of JPY 3,785.00, while the Japan Nikkei 225 also rose. The company has outperformed the index over various time frames, with a market capitalization of JPY 107,246 million and notable valuation metrics.

Tri Chemical Laboratories Inc. saw a significant increase today, reaching an intraday high while outperforming the Japan Nikkei 225. Despite recent gains, the company has faced longer-term challenges, including a decline over the past month and a five-year performance drop, though it maintains a solid market capitalization and P/E ratio.

Tri Chemical Laboratories Inc. faced notable volatility on March 16, 2026, with a significant daily decline and a cumulative drop over the past week and month. The company has underperformed the market over the past year, with declining net sales and a challenging financial position reflected in its metrics.

Tri Chemical Laboratories Inc. faced a notable decline in its stock today, contrasting with the broader market's performance. The company reported a decrease in net sales and a low operating cash flow, alongside a high debt-equity ratio. Despite these challenges, it maintains a positive return on equity and valuation metrics.

Tri Chemical Laboratories Inc. saw a significant stock decline today, contrasting with the broader market's performance. The company reported a decrease in net sales and operating cash flow, alongside a high debt-equity ratio. Despite a year-to-date gain, its annual return lags behind the market average.